Accurate Clinical Prediction Model for MRSA CAP Seen as Unlikely The authors write, "Although the identification of risk factors and development of clinical prediction models for MRSA CAP have generated great interest recently, our results suggest it is unlikely that a clinical prediction model could ...
Among patients that received vancomycin therapy for CAP, only 30% (21/70) and 17.3% (13/75) had risk factors warranting anti-MRSA therapy in the pre-PCR and post-PCR groups respectively. The median duration of vancomycin therapy was significantly shorter in the post-PCR group than the pre...
常用抗菌药物在MRSAHAP的临床应用 汕头大学医学院第一附属医院呼吸内科 吴洁文 HAP的流行病学 HAP发病率为0.5%－1.0%，居院内感染第二位，占所有院内感染的15%－20%。在ICU，HAP发病率高达18%－60%。肺炎患病危险每日增加1% Chest,2019,122:2115-2121.在美国，HAP病死率达30%－50%，入住ICU者HAP病死率...
移酶由 cfr 基因编码, 还可以(MRSA-CAP)的典型症状包括高热、低动脉压、 咳 介导细菌对氯霉素、克林霉素、 恶唑烷酮类及奎奴普 口血、快速的感染性休克 及需要呼吸支持。在美国, 丁等耐药。1997 年和 1998 年分别报道了 2 例 13 岁 和12 个月的儿 5.4 氨基糖苷类童感染 USA400 型 CA-MRSA 的病例 18...
单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,感染治疗,诊治,使用疗程,儿科,其他,骨关节感染,感染性心内膜炎,皮肤及软组织感染,中性粒细胞减少伴发热,中枢神经系统感染,血流感染,肺炎,经验性抗,治疗指征,一,社区获得
中国新药与临床杂志,2011,30(8):e561-573.XX年万古霉素治疗MRSA指南的临床药师的解读与研究MRSA感染治疗用药万古霉素治疗肺炎特别是HAP(含VAP)要求谷浓度达到15mg/l~20mg/l肾功能正常者给药剂量15-20mg/kgq8-12h感染类型治疗类型推荐CAP经验性联合MSSA敏感药物*直至鉴定为MRSA时改用万古霉素PRSP(分离率10%)目标...
J.Clin Infect Dis,2006,42(12):1764-1771.XX年万古霉素治疗MRSA指南的临床药师的解读与研究学习改变命运学习改变命运,知识创造未来知识创造未来PRSP=青霉素耐药的肺炎链球菌青霉素MIC4mg/ml时对内酰胺类严重过敏者如果存在PRSP风险(如发病前3个月内用过抗生素)住院(包括住ICU)的重症CAP患者治疗指征 经验性抗MRSA治...
Objective: The objective of the present study was to assess the incidence of community-acquired pneumonia (CAP) in children caused by Mycoplasma pneumon... M Korppi,T Heiskanenkosma,M Kleemola - 《Respirology》 被引量: 321发表: 2010年 Nursing home-acquired pneumonia: a 10 year single-centre...
Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of osilates Medicine (Baltimore), 92 (2013), pp. 98-108 View in ScopusGoogle Scholar [48] H.S. Ok, H.S. Lee, M.J. Park, K.H. Kim, B.K. Kim...
Transcription factors were thought to be mainly responsible for directing this process by controlling gene expression at the DNA level; however, it has become evident that a substantial amount of regulation occurs post-transcriptionally: RNA-binding proteins (RBPs), are now recognised as key players...